Pharsight

Acetaminophen generic

acetaminophen is a drug manufactured by Fresenius Kabi Usa. It contains the active ingredient acetaminophen, which is integral to its function. The drug was first authorised for market use on October 28, 2015, and to date, it holds a total of one patent, none of which have expired yet.

When will Acetaminophen generic be available?

The Acetaminophen generic could potentially be available after April 19, 2030. This release date is determined by the patent, US8741959, titled 'Paracetamol for parenteral administration' which is due to expire on April 19, 2030.

Acetaminophen uses

acetaminophen is used as a solution for intravenous administration. This pharmaceutical drug, thanks to its active component acetaminophen, serves to relieve pain and reduce fever.

Acetaminophen patent expiration

Acetaminophen holds one patent, US8741959, that is set to expire on April 19, 2030. This patent, titled 'Paracetamol for parenteral administration', is instrumental in determining the release date of the Acetaminophen generic. Below are the details of the patent:

EPO Oppostions filed on Acetaminophen

Acetaminophen dosage

Want to ask something?